• Royalty Pharma EPS for the quarter ending December 31, 2024 was $0.46, a 58.56% decline year-over-year.
• Royalty Pharma 2024 annual EPS was $1.91, a 24.51% decline from 2023.
• Royalty Pharma 2023 annual EPS was $2.53, a 2430% increase from 2022.
• Royalty Pharma 2022 annual EPS was $0.1, a 93.29% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.